The Effectiveness and Safety of Pharmacopuncture on Inpatients With Acute Knee Pain Caused by Traffic Accidents

NCT ID: NCT06931951

Last Updated: 2026-01-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-05-22

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to reveal the effectiveness and safety of knee herbal acupuncture for patients with acute knee joint pain caused by a traffic accident. It is a practical clinical study to confirm the comparative effectiveness by comparing the strategy of treating knee herbal acupuncture in parallel with the strategy of treating it with integrated oriental medicine treatment, which is an existing treatment method.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pharmacologic Action

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Knee Pharmacoacupuncture group

20 patients in the Knee Pharmacoacupuncture group

Group Type EXPERIMENTAL

Knee Pharmacoacupuncture

Intervention Type PROCEDURE

Physician choose the adequate type and dose of pharmacoacupuncture and needle type

Oriental medicine integrated treatment group

20 patients in the Oriental medicine integrated treatment group

Group Type ACTIVE_COMPARATOR

Oriental medicine integrated treatment

Intervention Type PROCEDURE

Physician choose the integrated oriental medicine treatment other than herbal acupuncture.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Knee Pharmacoacupuncture

Physician choose the adequate type and dose of pharmacoacupuncture and needle type

Intervention Type PROCEDURE

Oriental medicine integrated treatment

Physician choose the integrated oriental medicine treatment other than herbal acupuncture.

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Drug: Herbal extract-based pharmacopuncture Device: Acupuncture needles, cupping devices, and moxibustion devices, etc.

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* When the NRS (Numeric Rating Scale) of knee pain caused by a traffic accident is 5 or higher.
* Patients hospitalized for traffic accident treatment.
* Patients with acute pain within 14 days of experiencing knee pain due to a traffic accident.
* Patients aged between 19 and 70 years old.
* participants who agree to participate in clinical research and provide written test subject consent.

Exclusion Criteria

* For patients diagnosed with a specific serious disease that may cause knee pain (acute fracture, dislocation, complete rupture of ligaments, etc.)
* If the cause of the pain is caused by a disease other than the knee (tumor, fibromyalgia, rheumatoid arthritis, gout, lumbar disc herniation, etc.)
* Cases where surgical intervention is required due to suspected acute fracture, dislocation, or ligament and cartilage damage
* If there is another acute disease (stroke, myocardial infarction, kidney disease, diabetic neuropathy, dementia, epilepsy, etc.) that may interfere with the treatment effect or interpretation of results
* Patients currently taking steroids, immunosuppressants, mental illness drugs, or other drugs that may affect their findings
* Inadequate or unsafe medication: hemorrhagic disease, anticoagulant therapy, severe diabetic patients with risk of infection
* Patients who have taken drugs that may affect pain, such as Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), or have received herbal acupuncture or physical therapy within the past week
* In the case of pregnant women and in the case of planning to become pregnant or nursing
* Patients within 3 months after knee surgery or if knee replacement surgery was performed
* If it has been less than 1 month since participants finished participating in another clinical study, or if participants are planning to participate in another clinical study during the study participation and follow-up period within 6 months from the date of selection
* If it is difficult to fill out the consent form for research participation
* In cases where it is difficult for other researchers to participate in clinical research
Minimum Eligible Age

19 Years

Maximum Eligible Age

69 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Jaseng Medical Foundation

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Daejeon Jaseng Hospital of Korean Medicine

Daejeon, , South Korea

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

South Korea

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Sunah Kim KMD

Role: CONTACT

82-42-1577-0007

Eunyul Han KMD

Role: CONTACT

82-010-8343-0929

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

EUNYUL HAN, KMD

Role: primary

82-010-4440-3499

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

JS-CT-2025-02

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Moxibustion for Knee Osteoarthritis
NCT01354860 COMPLETED PHASE1/PHASE2
Acupuncture in Osteoarthritis of the Knee
NCT00325663 COMPLETED PHASE1/PHASE2